SignatureFD’s Inhibrx INBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.5K Hold
15
– – ﹤0.01% 3249
2026
Q2
$1.42K Hold
15
– – ﹤0.01% 3206
2026
Q1
$1.01K Buy
15
+13
+650% +$964 ﹤0.01% 3210
2025
Q4
$158 Hold
2
– – ﹤0.01% 3316
2025
Q3
$67 Hold
2
– – ﹤0.01% 3329
2025
Q2
$29 Sell
2
-40
-95% -$517 ﹤0.01% 3222
2025
Q1
$588 Sell
42
-86
-67% -$1.17K ﹤0.01% 3147
2024
Q4
$1.97K Sell
128
-58
-31% -$883 ﹤0.01% 2874
2024
Q3
$2.91K Hold
186
– – ﹤0.01% 2728
2024
Q2
$2.64K Buy
+186
New +$2.91K ﹤0.01% 2689

Other funds holding INBX

SignatureFD's INBX Position: Q3 2026 in Review

SignatureFD held its Inhibrx (INBX) position steady in Q3 2026 at 15 shares worth $1.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3249.

SignatureFD first reported a position in INBX in Q2 2024 and has held it in 10 quarters since. The position peaked at $2.91K in Q3 2024. 173 funds tracked by Wall St. Rank hold INBX as of Q3 2026.

  • SignatureFD held 15 shares of Inhibrx worth $1.5K as of Q3 2026.
  • SignatureFD left its Inhibrx share count unchanged in Q3 2026.
  • Inhibrx made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #3249 holding.
  • SignatureFD first reported a position in Inhibrx in Q2 2024 and has held it in 10 quarters since.
  • SignatureFD's Inhibrx position peaked at $2.91K in Q3 2024.
  • 173 funds tracked by Wall St. Rank held Inhibrx as of Q3 2026.

Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.